The DNA repair pathway as a therapeutic target to synergize with trastuzumab deruxtecan in HER2-targeted antibody–drug conjugate–resistant HER2-overexpressing breast cancerJangsoon Lee, Naoto T. Ueno|Journal of Experimental & Clinical Cancer Research|2024Cited by 24
The DNA repair pathway as a therapeutic target to synergize with trastuzumab deruxtecan in HER2-targeted antibody-drug conjugate–resistant HER2-overexpressing breast cancerJangsoon Lee, Naoto T. Ueno|Research Square|2023Cited by 2